Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Budesonide Powder
DRUG
2 trials
Sponsors
Imperial College London
, Cardresearch
Conditions
Asthma
Covid19
SARS-Associated Coronavirus
Phase 3
Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms
Recruiting
NCT04727424
Cardresearch
Covid19, SARS-Associated Coronavirus
Start: 2021-01-19
End: 2024-07-01
Target: 7819
Updated: 2024-05-08
Unknown Phase
Effect of Symbicort on GR Localisation in Asthma
Completed
NCT00159263
Imperial College London
Asthma
Start: 2004-11-30
End: 2006-11-30
Updated: 2019-09-27
Related Papers
Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial.
2024-08-15
1 citations
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.
2023-04-18
29 citations
Early Treatment with Pegylated Interferon Lambda for Covid-19
New England Journal of Medicine
2023-02-08
166 citations
Effect of Early Treatment with Ivermectin among Patients with Covid-19
New England Journal of Medicine
2022-03-30
216 citations
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.
2021-10-28
303 citations